Full Text View
Tabular View
No Study Results Posted
Related Studies
DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics (DIMS)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2008 by Genomas, Inc.
Recruitment status was  Recruiting
Study NCT00752960   Information provided by Genomas, Inc

First Received on September 12, 2008.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Psychoses
Additional conditions recognized in this trial
Mental Disorders
Psychotic Disorders
More general conditions related to this trial
Schizophrenia and Disorders with Psychotic Features
Additional drug interventions recognized in this trial
Antipsychotic Agents
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Genomas, Inc
Hartford Hospital
University of Kentucky


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services